Primary hyperoxaluria

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Primary hyperoxaluria | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Kidney stones, nephrocalcinosis, renal failure |
| Complications | End-stage renal disease, systemic oxalosis |
| Onset | Usually in childhood |
| Duration | Chronic |
| Types | Type 1, Type 2, Type 3 |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Genetic testing, urine oxalate levels |
| Differential diagnosis | Secondary hyperoxaluria, calcium oxalate stones |
| Prevention | None |
| Treatment | Pyridoxine, kidney transplantation, liver transplantation |
| Medication | Vitamin B6, potassium citrate |
| Prognosis | Variable, depends on type and treatment |
| Frequency | Rare |
| Deaths | N/A |
Overview of primary hyperoxaluria, a rare genetic disorder
Primary hyperoxaluria is a rare genetic disorder characterized by the overproduction of oxalate, a type of organic acid that combines with calcium to form calcium oxalate crystals. These crystals can accumulate in the kidneys and other organs, leading to kidney stones, nephrocalcinosis, and eventually renal failure.
Pathophysiology[edit]
Primary hyperoxaluria is caused by mutations in genes responsible for the metabolism of glyoxylate, a precursor to oxalate. The most common form, primary hyperoxaluria type 1, is due to mutations in the AGXT gene, which encodes the enzyme alanine-glyoxylate aminotransferase. This enzyme is crucial for converting glyoxylate to glycine, preventing its conversion to oxalate.
Types[edit]
There are three main types of primary hyperoxaluria:
- Primary hyperoxaluria type 1 (PH1): Caused by mutations in the AGXT gene.
- Primary hyperoxaluria type 2 (PH2): Caused by mutations in the GRHPR gene, affecting the enzyme glyoxylate reductase/hydroxypyruvate reductase.
- Primary hyperoxaluria type 3 (PH3): Caused by mutations in the HOGA1 gene, affecting the enzyme 4-hydroxy-2-oxoglutarate aldolase.
Symptoms[edit]
The symptoms of primary hyperoxaluria can vary but often include:
- Recurrent kidney stones
- Hematuria (blood in urine)
- Urinary tract infections
- Nephrocalcinosis
- Renal failure
Diagnosis[edit]
Diagnosis of primary hyperoxaluria involves:
- Measurement of oxalate levels in urine and plasma
- Genetic testing to identify mutations in the relevant genes
- Kidney imaging to detect stones or nephrocalcinosis
Treatment[edit]
Treatment strategies for primary hyperoxaluria include:
- High fluid intake to dilute urine
- Use of potassium citrate to inhibit stone formation
- Pyridoxine (vitamin B6) supplementation, particularly in PH1
- Liver transplantation in severe cases, especially for PH1
- Kidney transplantation in cases of renal failure
Prognosis[edit]
The prognosis for individuals with primary hyperoxaluria varies depending on the type and severity of the disease. Early diagnosis and management can improve outcomes, but many patients may eventually require dialysis or transplantation.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian